CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
Clinical trial NCT03605927 · COMPLETED
Trial details
- NCT number
- NCT03605927
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2023-07-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.